Electrical bioimpedance has been used over the years to measure various physiological parameters. Due to lack of high-speed instruments, there have been few options for making multi-frequency measurement series with high temporal resolution. This situation has changed lately, and with access to a commercially available impedance spectrometer, we have used this as part of an enhanced measurement set-up capable of measuring both bioimpedance and biopotentials with a temporal resolution in the millisecond-range. The set-up is controlled by a computer which also displays and processes the measurement data. Results from measurements in a human heart are shown. In these measurements, we can clearly see differences in the signal trajectory at current frequencies. The different trajectories indicate that with change in frequencies different physiological properties are reflected. We have shown that it is possible to detect changes in waveform morphology caused by a change in pacing modality. The ECG and EGM give additional information on global heart activity and electrical activity surrounding the electrodes. This measurement set-up allows us to further investigate bio-impedance as a measurement tool for rapid changes in impedance, such as in the cardiac field. The study was approved by the local institutional review boards (2014/1223/REK sør-øst A).
1. Introduction
Background
There are a number of available investigation methods available for the clinician when doing surgery on a patient with heart disease. This includes imaging methods (epicardial and intracardiac echocardiography, fluoroscopy), bio-signal measurement tools (electrocardigram, pressure), navigation tools (magnetic field and bioimpedance field) and so on. Due to limitations with access to the operation field, these methods cannot be used to a large and sufficient extent during implantation of cardiac pacemakers. We believe that electrical bioimpedance measurements due to the nature of application and acquisition, provides the properties needed to allow full access to the operating field during measurements. Electrical bioimpedance has been demonstrated to be safe and provide clinical relevant information in patients in several devices (e.g. Ensite from St Jude Medical [1] , OptiVol from Medtronic [2] , closed loop stimulation from biotronik [3] ), but the bioimpedance data is not available nor suitable for research purposes. On the other hand, it has been shown that bioimpedance may be useful during surgery [4] [5] [6] . Limitations in the equipment used in the previous bioimpedance measurements includes availability and lack of adaption for use on human subjects during surgery. We believe that useful information can be obtained from heart measurements on human subjects with equipment suitable to measure and present the results in real-time to the implanting surgeon.
About electrical bioimpedance and bioimpedance measurement
There are no medically approved bioimpedance instrument available that can be used straight out of the box, so our aim was to investigate present possibilities.
To better understand what we need, a few words on the application can be useful. We wanted to do three and four electrode measurements using a combination of electrodes placed on the subject's skin and the electrodes available on pacemaker leads during implantation of the pacemaker. An illustration of one possible electrode configuration is shown in figure 1 . This figure illustrates that we need to be able to measure impedances smaller than W 1 . In the other end, we expect that three-electrode measurements will present the highest impedances. Three electrode measurements done using needle electrodes has been shown to have an impedance of up to approximately W 2.5 k [7] for frequencies down to 10 kHz. Since we are aiming at measuring spectrums with a temporal resolution high enough to reflect rapid changes in the heart muscle, we decided to set our goal to at least 150 frequency sweeps per second, but preferably higher. Measurement frequency range was decided to be < = < = f 10 kHz 1 MHz Z based on risk of myocardial capture [8] , and the fact that parasitic components make measurements above 1 MHz difficult. The number of frequencies needed can be limited because there are no sudden changes in the spectrum [7, 9] . Other factors that are of importance is the instrument size since it is intended to be used on a small cart, it must be possible to control it using USB or Ethernet, and if possible, it should have available GPIO-pins.
Measurements of combined bioimpedance and biopotentials have been done for a long time [6, 10, 11] , but there is still no instrument capable of doing both operations. This meant that we could either make our own instrument or we could use an existing impedance spectrometer and a minimum of extras. We decided to not make an instrument from scratch due to the required resources. However, some of the technologies we looked at are very promising if commercialized and integrated into one product. In particular, we would like to draw attention to bioimpedance measurement using broadband excitation solutions as these seem to be offering a good compromise between speed and accuracy [12, 13] . There are three main excitation schemes: multisine [14] , chirp [15] , and binary [16] in use, but other schemes such as the one in [4] where the periodic impedance properties of the measurand are being exploited are also promising.
The instruments in table 1 summarizes the instruments we considered. Only the Solartron and Impedimed instruments was aimed for bioimpedance, but neither had the required safety-level.
Measurement of potentials has been done for more than 100 years [17] , and is a mature technology, and the availability of measurement devices is good. This allowed us to use a commercially available instrument with a cardiac floating (CF) approval.
Safety
Since this equipment is intended for use on humans, safety is a concern. IEC 60601-1 [18] or any of the substandards do not have bio-impedance specific requirements. Furthermore, IEC 60601-1 [18, 8.4 .1] states that connections intended to deliver current are not limited by the current limits specified in IEC 60601-1 [18, 8.4.2.] We have, however verified that the leakage between the applied part and the mains, including ground, is within the limits of CF specification. A riskassessment based on general requirements and substandard covering devices with excitation signal within the same range was done.
The results from the risk analysis and the applicability to the European Medical Devices Directive-93/42/EEC with 2007/47/EC, was evaluated and approved in accordance with Annex VIII by the appointed committee at Oslo University Hospital.
Aims
The aims of this work is to make a measurement system that:
(a) Facilitates real-time bioimpedance and biopotential measurements on human hearts.
(b) Presents data in real-time with sufficient quality and temporal resolution to extract morphological information from bioimpedance waveforms.
Materials and methods

Materials
Ten patients were included in this study. All patients were hospitalized to receive or replace a cardiac resynchronization (CRT) device. The first four subjects were used for the initial exploration of the capabilities, and the measurements protocol for the next six were identical. All patients were informed about the study and have signed a consent form. The study was approved by the local institutional review boards (2014/1223/REK sør-øst A).
Set-up description
The instrumentation system is based on several commercially available components that are assembled as shown in figure 2.
Bioimpedance measurements 2.3.1. Base instrument
The hardware is based on an ISX 3v2 mini from Sciospec Scientific Instruments GmbH, Bennewitz, Germany. This is an FPGA based impedance spectrometer instrument that can be controlled using an USB or ethernet interface. The instrument uses a stepped-sine approach for measuring impedance on multiple frequencies. For more information on this instrument, see [19] . We use the instrument via a front-end.
Front-end
The front-end is connected to the ISX3v2 mini via a coaxial cable bundle that contain power supply, control signals, and the four measurement signals. The basic functionality of the front-end can be seen in the schematic in figure 3 . To the left is the connector that connect measurement signals, control signals, and power to the front-end (XINST). The four measurement signals have identical signal paths to the patientside connectors. The signal paths are via switches SWX that allows the patient side to be disconnected from the instrument side. This is controlled by an ISX control signal (gray line) that is ultimately controlled by the computer. All the switches are operated simultaneously. Then follows two capacitors in series (C2X and C1X), acting as galvanic isolators. These capacitors are m 1 F, of enhanced-safety Y2-type [20] . Since the capacitors form the safety galvanic isolation, there is a 10 mm gap in the PCB-traces under the capacitors to limit the risk of stray currents. Finally, there are two resistors in series with a combined resistance of W 50 . It can be argued that these are not necessary, but they are included to limit high frequency currents should there be any, and are dimensioned so they do not affect the measurement too much. On the front-panel, there are three options to connect the front-end to the measurand: four singlepin connectors for the four impedance signals, a multi-pin connector that contain the same signals, or a combination of these. The single pin-connectors are 
Note. A full comparison is beyond the scope of this article, and deemed not necessary since the three instruments to the left fulfilled our specifications short of one feature: sufficient safety rating for heart measurements. Manufacturer and model names: Sciospec ISX 3v2, Zrich Instruments MFIA, Zurich Instruments HF2IS, Wayne Kerr WK6500, Keysight E4990A, Keysight E4991A, Solartron 1260 + 1294, and Impedimed Imp TM SFB7. * ) This is somewhat unclear from documentation, but according to sales representative, the sample rate is at least 200 samples per second.
**
) Sizes are small < 5 kcm 3 < medium < 20 kcm 3 < large. 
Biopotential measurements
The hardware is based on an g.USBamp from g.tec medical engineering GmbH, Schiedlberg, Austria. This instrument is a medically approved bio-potential measurement instrument which is CF-rated. It provides 16 analog inputs, each with sub-mV resolution and sample-rate up to 38 400 samples per second. The instrument has built-in digital filters. We chose to use 600 samples per second since we wanted comparable data rates for biopotentials and bioimpedances, and most information in the biopotential signals are in the band below 300 Hz. It is easy to change the sample rate should the need for higher temporal resolution arise. This instrument is used to measure ECG and electrograms (EGM). An electrogram is a biopotential measured in a heart chamber or in a specific position within a chamber. Figure 2 shows how the parts are connected, and the associated isolation scheme. The cart has a built-in isolation transformer witch supplies the other components. The cart itself is grounded.
Power supply and intra-cart communication
The bioimpedance measurement sub-system is powered via a medical-grade power supply unit. This unit is CF-rated, which means that it is approved for providing galvanically isolated power for devices that are connected directly to the heart. Both biopotential and bioimpedance instruments are controlled by the computer. Optically isolated ethernet communication is used for communication with the bioimpedance instrument (labeled G in figure 2 ).
Software
We made LabVIEW-based software to control the instruments, display results, and to save results to file. This software runs on a Windows-based computer (labelled F in figure 2) .
Bioimpedance data and biopotential data are displayed in real-time, and the user may choose to display impedance or admittance in either cartesian or polar form. The raw data, i.e. resistance (R) and reactance (X), can be filtered using Butterworth high-pass, lowpass, band-pass, or band-stop filters. As this software is based on LabVIEW, it is a simple operation to implement a wide range of filter topologies. Timestamped events and information describing the measurements can be saved along with the measurement data.
We have chosen to post-process the data using Matlab, using a set of functions that let us apply filters, remove pace artifacts, plot data, extract statistics, extract individual heart-beats, and perform beat-averaging. We intend to make this library available as a free toolbox for Matlab/Octave.
Measurements 2.7.1. Test loads
The measurement system was used to measure a selection of fixed loads to test precision. The loads are shown in figures 5 and 6. The test loads are of purely resistive for simplicity and since we at a later stage want to use the same loads using the built-in compensation feature of the ISX 3v2 mini, and that requires purely resistive or purely capacitive loads. These measurements indicate the raw precision of the system, and can furthermore be used for calibration. The measurements were done using four single-signal 100 cm unshielded test leads and one multi-signal shielded cable. The multi-signal cable has a 150 cm long trunk which splits to four 60 cm coaxial cables. In addition to measurement on the test loads, we measured the same fixture with = Z open DUT and = Z short DUT . The measured data can be used to compensate for parasitic components as described in [22, appendix C].
Heart measurements
We did heart measurements during normal implantation of CRT devices on ten patients. During this procedure, the cardiologist is accessing a vein in the left subclavian region, and inserts two or three leads that goes to right ventricle (RV) and left ventricle (LV) for all patients, and right atrium (RA) for some patients. The electrodes on these leads are accessible outside the body on the connectors that will be connected to the CRT device. This is a minimally invasive procedure.
We did measurements using the two different electrode configurations described in tables 2 and 3, using the instrument settings in table 4. For the four electrode measurements we applied bipolar pacing in RA and in RV, and then we changed to pacing in RA and in LV. For the three electrode measurement we applied pacing in RA and LV.
The measurement results were exported to Matlab for post-measurement processing and presentation. The processing done on these data are:
(a) Resampling to 400 samples per second.
(b) Added pace-information.
(c) Removal of pace-artefacts by analyzing signal activity around each pace event to find start and stop times for the pace interference, and replaced the signals by an interpolation in this region.
(d) Low pass filtering of R and X using a 2nd order Butterworth filter with pass-frequency 40 Hz was done on the waveforms shown, and no filtering was done on the waveforms used for correlation tests described below.
For this particular purpose, an Butterworth IIR filter is used, but if more control of phase is important, especially close to the cut-off frequency, FIR filters should be considered.
We aim to verify that we are able to detect morphology changes in the waveforms when we changed pacing modality. The hypothesis is that if we look at the correlation between waveforms obtained during RV pacing and during bi-ventricular (BV) pacing, we can differentiate between these. The null hypothesis (H 0 ) is then that that we cannot differentiate between these.
To test our hypothesis, we did this on the last six patients: (ii) In group I, we placed correlation coefficients of signals compared to the same pace regime, i.e. RV-signals compared to RV-signals, and BV-signals compared to BV-signals.
(iii) In group II, we placed correlation coefficients of signals compared to the another pace regime, i.e. RV-signals compared to BVsignals.
(f) We ran a one-tailed, two-sample t-test on these groups using a 5% significance level.
Results
Test loads
Measurement on test loads using different Z DUT and different cables gave a set of impedance values that can be used for compensation of parasitic components. These results are highly dependent on cables, testfixture, and configuration. Figure 7 gives us an impression of the accuracy of the system. The three most important facts that can be read out of the figure is that error increases at higher frequencies, error increases when Z DUT is very low or high, and that using the multi-signal cable is not as good as using individual cables. Figure 8 shows the results from the 4-electrode measurement where pacing is done in A and RV, and in figure 9 pacing was done in A and LV. The important point to note is that we can see changes in waveform morphology, and that it is feasible to extract timing information form the waveforms
Heart measurements
The correlation tests was run on six subject, five measurement frequencies per subject, and the impedance representations | | Z , Z  , R, and X, a total of 30 tests. Mean values of the correlation coefficients for each subject are shown in table 5. When the significance level was set to 0.05, H 0 was rejected for all cases except these:
(c) Subject 6, = f 50 kHz, X. Bi-polar pacemaker lead. In figure 10 , we can clearly see periodic changes in the waveform. As the sensitive electrode is placed in coronar sinus and is not anchored to the vein, there are probably several contributors to the periodicity such as: the electrode is moving across different tissue types in the heart as the electrode is moving in the heart, the heart is moving with respect to its surroundings, and the tissue itself change properties.
Pacing on bioimpedance potential pick-up electrodes causes artifacts in the measurements as shown in figure 11 . We did remove these during post-processing of the measurements, and the result of such an artifact removal is shown in figure 12. 4. Discussion
Overall system
We have made an instrumentation system for electrical bioimpedance and biopotentials. Biopotential measurements with acute feedback have been used for a long time in the form of ECG, EGM, and EEG, and has proven that it is useful. We believe that we can expand the tool-set for the clinician by making a system that combines measurements of biopotential and bioimpedance. As demonstrated in this article, we can do measurements on hearts, but we may easily use the measurement system in other settings where we have biopotentials and where bioimpedance might be of interest.
Bioimpedance measurements 4.2.1. The equipment
Since there is no existing bioimpedance measurement instrument available that can be used directly for measurements on human hearts, we had to create a set-up. In one end of the complexity-range, we have instrumentation made using and application-specific integrated circuit [23] , and in the other end we have instruments that only required a front-end. A highly integrated solution as presented in [23] could easily be made to fulfill our needs, but the downside is the amount of resources required to make a useful system. We considered solutions based on separate DAC and ADC's such as the one used in [4] and on FPGA-based solutions such as presented in [24] or Red Pitaya [25] . Common for these solutions is that there is still a substantial amount of work that need to be done to implement algorithms for impedance measurements, and to program the FPGA for the FPGA-solutions. What we considered the least complex system was one based on existing general-purpose instrument and a front-end. According to table 1, the current options are the Sciospec ISX 3v2, Zurich Instruments MFIA, and Zurich Instruments HF2IS. All of these could be used, but the MFIA was not available when this work started. Our choice of the ISX 3v2 mini instead of the HF2IS was based on several factors not obvious from table 1: it is physically smaller, it has high tolerance for high voltages coming from a pacemaker, the extension port contain everything needed to connect to the front-end using a single cable, and Ethernet interface enables simple medical grade galvanic isolation. Not choosing the HF2IS means that we chose an instrument that is using stepped sine excitation instead of a broadband excitation. As pointed out in [12] , this may not be the best solution if we are trying to optimize for high sample-rate. But since we are looking for a tool to use in an acute setting, we needed only about 200 samples per second. We do realize that for higher sample-rate or wider frequency range, the HF2IS or systems based on separate DAC and ADC's or FPGA must be considered. It should be mentioned that since the ISX 3v2 mini and the MFIA are FPGA based, they could probably be re-programmed by the vendors to implement a broadband excitation scheme.
It could be useful to measure more frequencies, over a wider range, or with higher precision, but all of these requirements will increase the time it takes to do a measurement, and thus reduce temporal resolution.
For example, if we are did a linear sweep from 10 kHz to 1 MHz using the same precision as we have used we would end up with 17 sweeps per second, and if we did a logarithmic sweep of 21 frequencies from 10 kHz to 1 MHz , we would end up with 32 sweeps per second.
The front-end is serving two main purposes: to make the set-up safe to use on human hearts and to provide a convenient way of connecting the equipment to the patient leads. The safety is handled by providing galvanic isolation in the two capacitors. In addition, the capacitors and the series resistors limit low-frequency currents that could otherwise cause myocardial capture [8] . Un-intended myocardial capture is not desired since it may cause myocardial fibrillation. The front-end is limiting the measurement frequency going towards lower measurement frequencies. This can be rectified by either calibration or increasing the capacitor values in the front-end. However, measuring at low frequencies means that sweeptime increases, resulting in lower temporal resolution.
Using color-coded connectors as shown in figure 4 to identify leads proved useful in practice. 
Accuracy and compensation
It is necessary to comply with the regulations and rules of the operation room where the measurements are done. This implies relatively long cables from the sterile zone to the instrumentation. These cables are shielded, which leads to low sensitivity to electromagnetic noise. But shielding introduce parasitic capacitances, which again can cause microphonic noise [26] . Microphonic noise is minimized by using low-noise ECG-cables. The effect of using shielded cables and unshielded single-signal cables was investigated, and results are shown in figure 7 . The figure shows that the accuracy is dependent on both measurement frequency, load, and cable type. It is possible to compensate for the parasitic effects in the cables by using a compensation scheme as described in [22, appendix C] . The point of compensation may be in the bioimpedance instrument, in the LabVIEW software, or during post-processing. We chose to do it during post-processing since we change cables several times during a procedure, and we do not need to have calibration data available beforehand. We have considered adding a compensation-module on the signals that are presented in real-time, while leaving the saved data un-compensated, but have not done this since the visual effect for the clinician is relatively small. It is an option to use unshielded cables or a flat ribbon cable, but these will be more sensitive to electromagnetic interference even if the parasitic capacitances are lower.
Another important point is that we do not have control over the parasitic components of the pacemaker leads and its surroundings. A number of different types are used, and they will have varying inductance, mutual inductance and capacitance between wires within a lead, varying capacitance to other leads or tissue, etc. The electrode surface parameters are likewise diverse. This makes it very difficult to compensate for this particular measurement set-up. As a workaround, we have chosen to focus on waveform morphology instead of absolute values. And in the cases where we only consider waveform morphology, compensation may in some cases be left out of the picture altogether as we have shown in section section 3.2.
Biopotential measurements
We have observed several types of artifacts in the biopotential data. The first is effects are from filtering of measurements. As expected, all filters change the morphology of a signal, and this happens on biopotential data as well. Most troublesome are the cases where there are large and rapid changes in the signal as for example the spikes in potential caused by sharing an electrode used for pacing with an electrode used for biopotential measurements. In this case, a solution could be to separate the electrodes used for pacing and biopotential measurements. Careful filter design may also help reduce the filter artifacts.
The bioimpedance measurement instrument is injecting current in the CC-electrodes, and if these are shared with, or are placed close to a biopotential electrode there will be interference in the biopotential measurements. If we analyze the current in the CCelectrodes we will find a frequency component that is equal to the sample frequency of the biopotential measurement, and this will interfere the biopotential measurement. The solution to this problem is to separate biopotential and bioimpedance electrodes or to use a low-pass filter on the biopotentials.
If an electrode used for pacing is shared with or are placed close to a biopotential electrode, the pace potential will be captured. A high spike can be removed using the semi-automatic pace artifact removal function in Matlab as illustrated in figures 11 and 12. This will remove the large and rapid changes, but since the pace signal voltage may be well above the input range of the instrument, we may experience effects caused by overloading of the input circuit. In figure 9 , we can see an example of this in the bottom biopotential plot.
Heart measurements
The heart measurements shown in figure 8 through 10 illustrates how the set-up can be used to see how impedance in the heart changes as a result of changed pacing. The provided results are examples, and full physiological interpretation of the two cases is outside the scope of this article.
In figures 8 and 9 , we see the effect of pacing in different positions. In figure 8 , pacing is done in A and RV, and in figure 9 pacing is done in A and LV. We can clearly see that that there is a steep change in impedance approximately 200 ms after the RV pace pulse in figure 8 , while the corresponding change is happening at the time of LV pacing in figure 9. We can also see different waveform morphology in the two cases. The small absolute values of the impedance are caused by small distance between the PU electrodes and that the CC current field is at an angle compared to the PU current field. The potential in the LV electrode is recorded, and is shown in figure 8 . The same potential is available in figure 9 , but since the electrode has been used for pacing the signal is effectively useless. In some patients the LV lead has four electrodes, in which case it could be possible to split the electrodes used for EGM and pacing. Figure 10 show the result of a three electrode measurement. Interpretation of the signals is not within the scope, but possible explanations may be change in impedance in the tissue surrounding the combined CC+ and PU+ electrode in a cardiac vein or movement of the heart which may move the electrode past different types of tissue that is contributing to the measured signal.
We have chosen to present impedance data as waveforms in the time-domain since we feel that this gives us most information. We did consider other representations such as fitting data to a model and than plot the model parameters, but decided against it for several reasons: data is lost when fitting to a model unless the model is very good, the cardiologists, who are the ultimate user of the data, are used to waveform representations of relevant physiological data, and finally, we have just begun exploration of how to utilize the measurement data. Even if we do not provide a full interpretation of the example waveforms, we have shown that we can use pacemaker leads together with the presented equipment to do morphological analyses of the waveforms The mean correlation coefficients shown in table 5 illustrates that the correlation of waveforms with identical pacing is higher than it is for waveforms with different pacing. The most interesting data in this table is for the three cases where H 0 were not rejected. The mean values are different, but not significantly so with a significance level of 0.05. If we changed the significance level to 0.1, H 0 would be rejected for all tests.
It is clear from figure 11 that both impedance data and potential data can be affected by pacing. Removal of pace artifacts is being done post-measurement since it requires information about pacing, and this information is not available at the time of measurement. The signals in figure 11 after pace artifacts are removed is shown in figure 12 . To remove pace artifacts in realtime, we would need information on the pacing, and in addition, a small time-delay would be introduced. We could extract the pace-rate automatically in some cases, but in several pace schemes, the rate is not 
